<DOC>
	<DOC>NCT00690482</DOC>
	<brief_summary>The purpose of this study is to study efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease</brief_summary>
	<brief_title>Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>FEV1 between 30 and 80% of predicted normal value postbronchodilator (GOLD stages 2 and 3) Clinical diagnosis of COPD Other clinically relevant disease or disorders Exacerbation of COPD within 30 days</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>COPD</keyword>
</DOC>